Sector Category: Life Sciences

Ventyx Biosciences

Ventyx Biosciences

Developing selective inhibitors of TYK2 for autoimmune diseases.

Read More
Morrow

Morrow

Focused on the commercialization of spectacles with digital lens technology.

Read More
ChromaCure

ChromaCure

Focused on the development of a first-in-class oncology therapeutic.

Read More
NorthSea Therapeutics

NorthSea Therapeutics

Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.

Read More
Seahorse Bioscience

Seahorse Bioscience

Acquired by Agilent Technologies. Developer of tools for measuring cell metabolism.

Read More
K2M

K2M

Acquired by Welsh, Carson, Anderson & Stowe. Developer of solutions for the treatment of complex spinal pathologies.

Read More
FlowCardia

FlowCardia

Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.

Read More
Dezima

Dezima

Acquired by Amgen. Focused on the development of a small molecule therapy for dyslipidemia.

Read More
Conor Medsystems

Conor Medsystems

Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.

Read More
Ception

Ception

Acquired by Cephalon. Focused on the development of a biologic therapy for the treatment of asthma.

Read More
Biovex

Biovex

Acquired by Amgen. Focused on the development of an oncolytic vaccine for melanoma and head and neck cancer.

Read More
Akarna Therapeutics

Akarna Therapeutics

Acquired by Allergan. Focused on the development of a small molecule therapy for the treatment of NASH.

Read More